Heightened levels of circulating 20S proteasome in critically ill patients.
about
Regulating the 20S proteasome ubiquitin-independent degradation pathway.Circulating proteasomes after burn injuryCirculating 20S proteasome is independently associated with abdominal muscle mass in hemodialysis patients.The value of correlation of serum 20S proteasome concentration and percentage of lymphocytic apoptosis in critically ill patients: a prospective observational studyDistinct proteasome subpopulations in the alveolar space of patients with the acute respiratory distress syndromeUbiquitination and proteolysis in acute lung injurySerum 20S proteasome is elevated in patients with renal cell carcinoma and associated with poor prognosis.Free radical-mediated skeletal muscle dysfunction in inflammatory conditions.Circulating 20S proteasome levels in patients with mixed connective tissue disease and systemic lupus erythematosus.Effect of proteasome inhibitors on endotoxin-induced diaphragm dysfunction.Proteasomes in human bronchoalveolar lavage fluid after burn and inhalation injury.Current understanding on the role of standard and immunoproteasomes in inflammatory/immunological pathways of multiple sclerosis.Extracellular proteasome-osteopontin circuit regulates cell migration with implications in multiple sclerosis.Intensive care unit-acquired weakness: clinical phenotypes and molecular mechanisms.The proteasome: mechanisms of biology and markers of activity and response to treatment in multiple myeloma.Therapeutic Approaches in Mitochondrial Dysfunction, Proteolysis, and Structural Alterations of Diaphragm and Gastrocnemius in Rats With Chronic Heart Failure.Pharmacological strategies in lung cancer-induced cachexia: effects on muscle proteolysis, autophagy, structure, and weakness.Enzymatic activities of circulating plasma proteasomes in newly diagnosed multiple myeloma patients treated with carfilzomib, lenalidomide and dexamethasone.Dysregulation of ubiquitin-proteasome pathway and apolipoprotein A metabolism in sickle cell disease-related pulmonary arterial hypertension.T lymphocytes export proteasomes by way of microparticles: a possible mechanism for generation of extracellular proteasomes.Role of the human erythrocyte in generation and storage of asymmetric dimethylarginine.The extrinsic caspase pathway modulates endotoxin-induced diaphragm contractile dysfunction.Alveolar extracellular 20S proteasome in patients with acute respiratory distress syndrome.Caspase activation contributes to endotoxin-induced diaphragm weakness.Proteomic analysis of affinity-purified extracellular proteasomes reveals exclusively 20S complexes.Immunoproteasome in the blood plasma of children with acute appendicitis, and its correlation with proteasome and UCHL1 measured by SPR imaging biosensors.Circulating extracellular proteasome in the cerebrospinal fluid: a study on concentration and proteolytic activity.An extracellular proteasome releases endostatin from human collagen XVIII.Proteomic profiling of the plasma of Gambian children with cerebral malariaProteasome Activity and C-Reactive Protein Concentration in the Course of Inflammatory Reaction in Relation to the Type of Abdominal Operation and the Surgical Technique Used
P2860
Q34318192-22D59335-8AF5-4D96-B9F7-2CA34DB93757Q34665247-D21889E0-A1C2-4527-BEDF-F226E3B58362Q35214455-FC2B250B-F2C7-45AB-AB02-25DB8AC85770Q35561323-17C6163F-3AEF-42A0-94FD-2DAFE4FBFEE0Q35738931-C824F54F-4B21-4428-AC8D-01886565649FQ35811448-DF106690-5374-47D0-BE6A-A911606BAAC1Q35835132-7D0EE61B-9084-48A0-AF34-FDAF652A0B3CQ36705832-D48B06FF-52BC-4C6D-97B3-1D64BA8A1CBFQ36898023-9D9D50C3-554D-46A6-A888-B15C398D18CCQ37218019-9E5929C1-B4E7-4ED3-BF4F-11C39B655D8DQ37524459-E62A7173-1C61-48B2-9D11-AB852DAC6ECBQ37541906-829C6A40-7956-4A7D-8CEA-5C668CE94AA8Q37690125-0387B295-D1A5-454B-AA71-81956ABF2EC8Q38064396-5B2B20B2-DCC5-4DA6-AEDA-8BEC4462FC24Q38164821-0B1DEAF2-814B-4764-898D-5464A036F159Q38946714-8E011E44-2562-4ED7-B97E-2DC571CDD2D1Q39016673-EAD812DA-8D2E-4C17-921B-58178CEE2BE0Q39336938-19CFB857-ABF2-4D51-B97A-AC0FF5D68F65Q41181352-FBFD3C48-505C-4CE8-9B33-07D83EE1A0E1Q41923180-885A8EDA-DABD-409C-A1AC-F4CF4D941D31Q42502690-2BC3F062-A565-4AF7-AD77-23BB98665514Q44554972-3E5ED11E-CE68-4576-9D82-80C0B53FBFE0Q46088115-9D4AE81A-9CF5-4C6C-AE74-90F7887E3C41Q46949571-6A6D0537-1445-433E-9DA9-6AAFDCC111B5Q47280042-35B7E254-F678-4E95-8853-11918250116FQ47757096-143EF77D-FDB0-40EB-B5EC-DA3E2F76D147Q48923815-1E3EC70E-47C3-446A-977A-847DBD1302D8Q51283766-9DA8EBE0-6041-4C11-8E98-2CAC17239AACQ57726311-81250612-311D-49EB-9A04-FD3B0DB7EF29Q58567864-4E5F6035-B9B5-4A26-84B2-3C859B1269CF
P2860
Heightened levels of circulating 20S proteasome in critically ill patients.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Heightened levels of circulating 20S proteasome in critically ill patients.
@en
Heightened levels of circulating 20S proteasome in critically ill patients.
@nl
type
label
Heightened levels of circulating 20S proteasome in critically ill patients.
@en
Heightened levels of circulating 20S proteasome in critically ill patients.
@nl
prefLabel
Heightened levels of circulating 20S proteasome in critically ill patients.
@en
Heightened levels of circulating 20S proteasome in critically ill patients.
@nl
P2093
P2860
P50
P1476
Heightened levels of circulating 20S proteasome in critically ill patients
@en
P2093
Ankersmit HJ
Boltz-Nitulescu G
P2860
P304
P356
10.1111/J.1365-2362.2005.01508.X
P50
P577
2005-06-01T00:00:00Z